Meeting Banner
Abstract #4749

Prebiopsy mpMRI to Increase the Detection Rate and Reduce the Overdiagnosis of Prostate Cancer

Sujeet Kumar Mewar1, Sanjay Sharma2, Sanjay Thulka3, Ekta Dhamijia3, Pradeep Kumar1, Sridhar Panaiyadiyan4, Rama Jayasundar1, S. Senthil Kumaran1, S. Datta Gupta5, N.R. Jagannathan6, Rajeev Kumar4, and Virendra kumar1
1Department of NMR, All India Institute of Medical Sciences, New Delhi, India, Ansari nagar, India, 2Department of Radio-diagnosis, RPC, All India Institute of Medical Sciences, New Delhi, India, Ansari nagar, India, 3Department of Radio-diagnosis, IRCH, All India Institute of Medical Sciences, New Delhi, India, Ansari nagar, India, 4Department of Urology, All India Institute of Medical Sciences, New Delhi, India, Ansari nagar, India, 5Department of Pathology, All India Institute of Medical Sciences, New Delhi, India, Ansari nagar, India, 6Present address.Department of Radiology, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India

The results of the study showed that mpMRI guided in-bore biopsy has the potential to increase the detection rate of PCa. Prebiopsy mpMRI of prostate was used for identification of suspicious areas of malignancy which were targeted for PCa detection and reducing unnecessary biopsies. The detection rate was compared with TRUS guided 12 core biopsy. The data also indicated that using prebiopsy mpMRI may also help to reduce unnecessary biopsies. The PCa detection rate of in-bore mpMRI targeted biopsy was 53.84 % compared to 37.27% for TRUS guided biopsy.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here